Pharmacokinetic analysis and k-means clustering of DCEMR images for radiotherapy outcome prediction of advanced cervical cancers

Acta Oncologica

Volumn 50, Issue 6, 2011, Pages 859-865

  Andersen, Erlend K F ^a   Kristensen, Gunnar B ^a   Lyng, Heidi ^a   Malinen, Eirik ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GADOLINIUM PENTETATE; IOPROMIDE; PENTETIC ACID;

ADVANCED CANCER; BRACHYTHERAPY; CANCER CONTROL; CANCER INFILTRATION; CANCER PATIENT; CANCER RELAPSE; CHEMORADIOTHERAPY; CONFERENCE PAPER; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOKINETICS; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; RADIOTHERAPY; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR VOLUME; UTERINE CERVIX CANCER; VASCULARIZATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CONTRAST MEDIA; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS; SURVIVAL RATE; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

EID: 79960483779     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.578586     Document Type: Conference Paper

References (26)

1. Glunde K, Pathak AP, Bhujwalla ZM. Molecular-functional imaging of cancer: To image and imagine. Trends Mol Med 2007;13:287-97. (Pubitemid 47017002)
2. Sovik A, Malinenv E, Olsen DR. Strategies for biologic image-guided dose escalation: A review. Int J Radiat Oncol Biol Phys 2009;73:650-8.
3. Busk M, Horsman MR, Overgaard J. Resolution in PET hypoxia imaging: Voxel size matters. Acta Oncol 2008;47: 1201-10.
4. Roe K, Muren LP, Rorvik J, Olsen DR, Dahl O, Bakke A, et al. Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy. Acta Oncol 2008;47:1257-64.
5. Malinen E, Sovik A, Hristov D, Bruland OS, Olsen DR. Adapting radiotherapy to hypoxic tumours. Phys Med Biol 2006;51:4903-21. (Pubitemid 44429851)
6. Rodal J, Sovik A, Malinen E. Infl uence of MLC leaf width on biologically adapted IMRT plans. Acta Oncol 2010; 49:1116-23.
7. Haney CR, Parasca AD, Fan X, Bell RM, Zamora MA, Karczmar GS, et al. Characterization of response to radiation mediated gene therapy by means of multimodality imaging. Magn Reson Med 2009;62:348-56.
8. Loncaster JA, Carrington BM, Sykes JR, Jones AP, Todd SM, Cooper R, et al. Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002;54:759-67.
9. Yuh WT, Mayr NA, Jarjoura D, Wu D, Grecula JC, Lo SS, et al. Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer. Invest Radiol 2009;44:343-50.
10. Tanderup K, Nielsen SK, Nyvang GB, Pedersen EM, Rohl L, Aagaard T, et al. From point A to the sculpted pear: MR image guidance signifi cantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer. Radiother Oncol 2010;94:173-80.
11. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffus-able tracer: Standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-32. (Pubitemid 29463104)
12. Korporaal JG, van den Berg CA, Jeukens CR, Groenendaal G, Moman MR, Luijten P, et al. Dynamic contrast-enhanced CT for prostate cancer: Relationship between image noise, voxel size, and repeatability. Radiology 2010;256:976-84.
13. Pintaske J, Martirosian P, Graf H, Erb G, Lodemann KP, Claussen CD, et al. Relaxivity of gadopentetate dimeglumine (magnevist), gadobutrol (gadovist), and gadobenate dimeg-lumine (multihance) in human blood plasma at 0.2, 1.5, and 3 tesla. Invest Radiol 2006;41:213-21. (Pubitemid 44406181)
14. Maimon O, Rokach L. Data mining and knowledge discovery handbook. New York: Springer Science + Business Media; 2005.
15. Yang C, Stadler WM, Karczmar GS, Milosevic M, Yeung I, Haider MA. Comparison of quantitative parameters in cervix cancer measured by dynamic contrast-enhanced MRI and CT. Magn Reson Med 2010;63:1601-9.
16. Meng R, Chang SD, Jones EC, Goldenberg SL, Kozlowski P. Comparison between population average and experimentally measured arterial input function in predicting biopsy results in prostate cancer. Acad Radiol 2010;17:520-5.
17. Huang W, Wang Y, Panicek DM, Schwartz LH, Koutcher JA. Feasibility of using limited-population-based average R10 for pharmacokinetic modeling of osteosarcoma dynamic con-trast-enhanced magnetic resonance imaging data. Magn Reson Imaging 2009;27:852-8.
18. Lavini C, Verhoeff JJ. Reproducibility of the gadolinium concentration measurements and of the fi tting parameters of the vascular input function in the superior sagittal sinus in a patient population. Magn Reson Imaging 2010;28: 1420-30.
19. Kim S, Loevner LA, Quon H, Kilger A, Sherman E, Weinstein G, et al. Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2010;31:262-8.
20. Semple SI, Harry VN, Parkin DE, Gilbert FJ. A combined pharmacokinetic and radiologic assessment of dynamic con-trast-enhanced magnetic resonance imaging predicts response to chemoradiation in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2009;75:611-7.
21. Zahra MA, Tan LT, Priest AN, Graves MJ, Arends M, Crawford RA, et al. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys 2009;74:766-73.
22. Gulliksrud K, Ovrebo KM, Mathiesen B, Rofstad EK. Dif-ferentiation between hypoxic and non-hypoxic experimental tumors by dynamic contrast-enhanced magnetic resonance imaging. Radiother Oncol 2011;98:360-4.
23. Egeland TA, Gaustad JV, Galappathi K, Rofstad EK. Mag-netic resonance imaging of tumor necrosis. Acta Oncol 2011;50:427-34.
24. Cao Y, Li D, Shen Z, Normolle D. Sensitivity of quantitative metrics derived from DCE MRI and a pharmacokinetic model to image quality and acquisition parameters. Acad Radiol 2010;17:468-78.
25. Korporaal JG, van den Berg CA, Groenendaal G, Moman MR, van Vulpen M, van der Heide UA. The use of probability maps to deal with the uncertainties in prostate cancer delineation. Radiother Oncol 2010;94:168-72.
26. Nielsen T, Mouridsen K, Maxwell RJ, Stodkilde-Jorgensen H, Ostergaard L, Horsman MR. Segmentation of dynamic contrast enhanced magnetic resonance imaging data. Acta Oncol 2008;47:1265-70.